CLINICAL_TRIALS
research
· 2025-12-17
Clinical Trial Update: Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY) [Phase 2]
Summary
A Phase 2 clinical trial is evaluating liraglutide in patients with Maturity-onset diabetes of the young (MODY), currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mansa | Conditions: Maturity Onset Diabetes of the Young | Phase 2 | Status: RECRUITING